Genpact (G)
NYSE:G
Want to see G full AI Analyst Report?
Top Page
Genpact
(NYSE:G)
Select Model
Select Model
Rating:73Outperform
Price Target:
$38.00
▲(11.18% Upside)
Action:ReiteratedDate:04/30/26
The score is driven by strong fundamentals (steady growth, improving leverage, solid cash generation) and a favorable earnings-call setup with upbeat 2026 guidance and ATS momentum. These strengths are partially offset by weak technicals (below key moving averages with negative MACD) despite oversold readings, while valuation appears reasonable with a moderate P/E and a ~2% dividend yield.
Positive Factors
Advanced Technology Solutions (ATS) acceleration
Sustained high-teens ATS growth signals a structural shift toward higher-value, technology-led services. A larger ATS mix improves revenue durability, drives higher incremental margins versus labor-heavy BPS, and supports scalable product and subscription-like revenue streams over multiple years.
Negative Factors
Net margin step-down since 2023
A sustained decline in net margin indicates pressures (tax, financing, non-operating items) that can erode after-tax profitability even if operating margins improve. If below-the-line costs persist, EPS growth and return metrics could lag operating performance over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Advanced Technology Solutions (ATS) acceleration
Sustained high-teens ATS growth signals a structural shift toward higher-value, technology-led services. A larger ATS mix improves revenue durability, drives higher incremental margins versus labor-heavy BPS, and supports scalable product and subscription-like revenue streams over multiple years.
Read all positive factors
Genpact (G) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.90B
Dividend Yield1.41%
Average Volume (3M)2.20M
Price to Earnings (P/E)14.7
Beta (1Y)0.73
Revenue Growth6.60%
EPS Growth10.28%
CountryUS
Employees145,000
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)0.97
Shares Outstanding169,762,710
10 Day Avg. Volume2,339,340
30 Day Avg. Volume2,198,049
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)3.19
Price to Sales (P/S)1.60
P/FCF Ratio11.07
Enterprise Value/Market Cap1.13
Enterprise Value/Revenue1.31
Enterprise Value/Gross Profit3.64
Enterprise Value/Ebitda7.74
Forecast
1Y Price Target
$46.17Price Target Upside35.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)4.02
Revenue Forecast (FY)$5.44B
Genpact Business Overview & Revenue Model
Company Description
Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods,...
How the Company Makes Money
Genpact makes money by providing contracted services to enterprise clients, generating revenue primarily from fees for ongoing operations management (managed services/business process services) and project-based professional services (consulting, ...
Genpact Key Performance Indicators (KPIs)
Any
Number of Clients Greater Than $25m Revenue
Indicates the number of major clients contributing significantly to revenue, highlighting reliance on large accounts and potential risks if any major client is lost.
Indicates the number of major clients contributing significantly to revenue, highlighting reliance on large accounts and potential risks if any major client is lost.
Data provided by:
The Fly
The FlyGenpact Earnings Call Summary
Earnings Call Date:Feb 05, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Positive
The call conveyed strong, broad-based progress: record revenue, significant acceleration in Advanced Technology Solutions (ATS), meaningful margin expansion, robust bookings and backlog, accelerating agentic (AgenTeq) traction, expanding product pipeline and partner momentum, and disciplined capital returns. Weaknesses were limited: softness in decision support services, modest consumer & healthcare growth, some reliance on a client prepayment for cash-flow benefit, variable large-deal timing, ongoing client productivity demands, and a higher effective tax rate. Overall, positives (growth, margin expansion, bookings, product/AI momentum) materially outweigh the listed challenges, and management provided constructive 2026 guidance.Positive Updates
Record Annual Revenue
Full-year 2025 revenue of $5.08 billion, up 6.6% year over year, marking a record year for Genpact.
Negative Updates
Softness in Decision Support Services
Core business services growth was partially offset by softness in decision support services in Q4, weighing on overall core segment momentum.
Read all updates
Q4-2025 Updates
Positive
Negative
Record Annual Revenue
Full-year 2025 revenue of $5.08 billion, up 6.6% year over year, marking a record year for Genpact.
Read all positive updates
Company Guidance
Genpact guided to at least 7% revenue growth for fiscal 2026 (as‑reported) with Advanced Technology Solutions accelerating to at least high‑teens growth, full‑year gross margin expanding ~50 basis points to 36.5% and adjusted operating income margin up ~25 basis points to 17.7%, driving ~10% growth in adjusted diluted EPS (outpacing revenue); management reiterated a balanced capital allocation approach targeting roughly 50% of operating cash flow returned to shareholders via buybacks/dividends and announced a 10% increase in the regular quarterly dividend, noted committed revenue near historical levels (~75%) and a record backlog, and provided Q1 targets of $1.282–$1.294 billion revenue (≈6% growth at midpoint), ATS accelerating to high‑teens, Q1 gross margin 36.3%, Q1 adjusted operating income margin 17.3% and adjusted diluted EPS of $0.92–$0.93.Genpact Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
83
Very Positive
Cash Flow
75
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.08B | 4.77B | 4.48B | 4.37B | 4.02B |
| Gross Profit | 1.81B | 1.69B | 1.57B | 1.54B | 1.43B |
| EBITDA | 874.70M | 852.58M | 772.52M | 652.86M | 709.01M |
| Net Income | 552.49M | 513.67M | 631.25M | 353.40M | 369.45M |
Balance Sheet | |||||
| Total Assets | 5.84B | 4.99B | 4.81B | 4.59B | 4.98B |
| Cash, Cash Equivalents and Short-Term Investments | 1.20B | 671.61M | 583.67M | 646.76M | 899.46M |
| Total Debt | 1.76B | 1.45B | 1.50B | 1.70B | 2.00B |
| Total Liabilities | 3.29B | 2.60B | 2.56B | 2.76B | 3.08B |
| Stockholders Equity | 2.55B | 2.39B | 2.25B | 1.83B | 1.90B |
Cash Flow | |||||
| Free Cash Flow | 734.65M | 530.19M | 432.04M | 389.28M | 637.03M |
| Operating Cash Flow | 812.86M | 615.42M | 490.81M | 443.67M | 694.28M |
| Investing Cash Flow | -495.50M | -105.96M | -78.94M | -36.59M | -122.75M |
| Financing Cash Flow | -106.81M | -424.85M | -483.00M | -571.40M | -332.88M |
Genpact Technical Analysis
Neutral
34.18
Price Trends
38.03
Negative
41.87
Negative
42.12
Negative
Market Momentum
-0.73
Negative
47.57
Neutral
59.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For G, the sentiment is Neutral. The current price of 34.18 is below the 20-day moving average (MA) of 36.96, below the 50-day MA of 38.03, and below the 200-day MA of 42.12, indicating a bearish trend. The MACD of -0.73 indicates Negative momentum. The RSI at 47.57 is Neutral, neither overbought nor oversold. The STOCH value of 59.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for G.
Genpact Risk Analysis
Genpact disclosed 43 risk factors in its most recent earnings report. Genpact reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Genpact Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $5.90B | 14.72 | 21.81% | 1.41% | 6.60% | 10.28% | |
73 Outperform | $4.87B | 17.71 | 27.16% | ― | 13.35% | 18.39% | |
68 Neutral | $6.00B | 30.32 | 10.27% | ― | 15.42% | -14.70% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $1.92B | 6.07 | 13.41% | ― | -3.09% | ― | |
54 Neutral | $3.12B | 26.53 | 20.43% | ― | 0.11% | 82.67% |
* Technology Sector Average
G
Genpact
34.33
-14.43
-29.59%
EPAM
Epam Systems
112.33
-46.79
-29.41%
EXLS
Exlservice Holdings
31.74
-14.80
-31.80%
DXC
DXC Technology
11.88
-4.00
-25.19%
KD
Kyndryl Holdings Incorporation
14.36
-19.17
-57.17%
Genpact Corporate Events
Business Operations and StrategyShareholder Meetings
Genpact Shareholders Back Board, Pay and Auditor at AGM
Positive
Apr 29, 2026
On April 23, 2026, Genpact Limited held its 2026 annual general meeting of shareholders in New York, where investors voted on board composition, executive pay, and the company’s external auditor. Shareholders elected all nominated directors ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.